NexImmune (NASDAQ: NEXI)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of NexImmune (NASDAQ: NEXI) through any online brokerage.
The latest price target for NexImmune (NASDAQ: NEXI) was reported by Barclays on Friday, April 1, 2022. The analyst firm set a price target for 7.00 expecting NEXI to rise to within 12 months (a possible 238.16% upside). 3 analyst firms have reported ratings in the last year.
The stock price for NexImmune (NASDAQ: NEXI) is $2.07 last updated May 23, 2022, 8:00 PM UTC.
There are no upcoming dividends for NexImmune.
NexImmune’s Q2 earnings are confirmed for Monday, August 8, 2022.
There is no upcoming split for NexImmune.
NexImmune is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.